Cargando…

Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy

BACKGROUND: Myocardial scar burden quantified using late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR), has important prognostic value in hypertrophic cardiomyopathy (HCM). However, nearly 50% of HCM patients have no scar but undergo repeated gadolinium-based CMR over their li...

Descripción completa

Detalles Bibliográficos
Autores principales: Fahmy, Ahmed S., Rowin, Ethan J., Arafati, Arghavan, Al-Otaibi, Talal, Maron, Martin S., Nezafat, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235098/
https://www.ncbi.nlm.nih.gov/pubmed/35761339
http://dx.doi.org/10.1186/s12968-022-00869-x
_version_ 1784736235297701888
author Fahmy, Ahmed S.
Rowin, Ethan J.
Arafati, Arghavan
Al-Otaibi, Talal
Maron, Martin S.
Nezafat, Reza
author_facet Fahmy, Ahmed S.
Rowin, Ethan J.
Arafati, Arghavan
Al-Otaibi, Talal
Maron, Martin S.
Nezafat, Reza
author_sort Fahmy, Ahmed S.
collection PubMed
description BACKGROUND: Myocardial scar burden quantified using late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR), has important prognostic value in hypertrophic cardiomyopathy (HCM). However, nearly 50% of HCM patients have no scar but undergo repeated gadolinium-based CMR over their life span. We sought to develop an artificial intelligence (AI)-based screening model using radiomics and deep learning (DL) features extracted from balanced steady state free precession (bSSFP) cine sequences to identify HCM patients without scar. METHODS: We evaluated three AI-based screening models using bSSFP cine image features extracted by radiomics, DL, or combined DL-Radiomics. Images for 759 HCM patients (50 ± 16 years, 66% men) in a multi-center/vendor study were used to develop and test model performance. An external dataset of 100 HCM patients (53 ± 14 years, 70% men) was used to assess model generalizability. Model performance was evaluated using area-under-receiver-operating curve (AUC). RESULTS: The DL-Radiomics model demonstrated higher AUC compared to DL and Radiomics in the internal (0.83 vs 0.77, p = 0.006 and 0.78, p = 0.05; n = 159) and external (0.74 vs 0.64, p = 0.006 and 0.71, p = 0.27; n = 100) datasets. The DL-Radiomics model correctly identified 43% and 28% of patients without scar in the internal and external datasets compared to 42% and 16% by Radiomics model and 42% and 23% by DL model, respectively. CONCLUSIONS: A DL-Radiomics AI model using bSSFP cine images outperforms DL or Radiomics models alone as a scar screening tool prior to gadolinium administration. Despite its potential, the clinical utility of the model remains limited and further investigation is needed to improve the accuracy and generalizability. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12968-022-00869-x.
format Online
Article
Text
id pubmed-9235098
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92350982022-06-28 Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy Fahmy, Ahmed S. Rowin, Ethan J. Arafati, Arghavan Al-Otaibi, Talal Maron, Martin S. Nezafat, Reza J Cardiovasc Magn Reson Research BACKGROUND: Myocardial scar burden quantified using late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR), has important prognostic value in hypertrophic cardiomyopathy (HCM). However, nearly 50% of HCM patients have no scar but undergo repeated gadolinium-based CMR over their life span. We sought to develop an artificial intelligence (AI)-based screening model using radiomics and deep learning (DL) features extracted from balanced steady state free precession (bSSFP) cine sequences to identify HCM patients without scar. METHODS: We evaluated three AI-based screening models using bSSFP cine image features extracted by radiomics, DL, or combined DL-Radiomics. Images for 759 HCM patients (50 ± 16 years, 66% men) in a multi-center/vendor study were used to develop and test model performance. An external dataset of 100 HCM patients (53 ± 14 years, 70% men) was used to assess model generalizability. Model performance was evaluated using area-under-receiver-operating curve (AUC). RESULTS: The DL-Radiomics model demonstrated higher AUC compared to DL and Radiomics in the internal (0.83 vs 0.77, p = 0.006 and 0.78, p = 0.05; n = 159) and external (0.74 vs 0.64, p = 0.006 and 0.71, p = 0.27; n = 100) datasets. The DL-Radiomics model correctly identified 43% and 28% of patients without scar in the internal and external datasets compared to 42% and 16% by Radiomics model and 42% and 23% by DL model, respectively. CONCLUSIONS: A DL-Radiomics AI model using bSSFP cine images outperforms DL or Radiomics models alone as a scar screening tool prior to gadolinium administration. Despite its potential, the clinical utility of the model remains limited and further investigation is needed to improve the accuracy and generalizability. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12968-022-00869-x. BioMed Central 2022-06-27 /pmc/articles/PMC9235098/ /pubmed/35761339 http://dx.doi.org/10.1186/s12968-022-00869-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Fahmy, Ahmed S.
Rowin, Ethan J.
Arafati, Arghavan
Al-Otaibi, Talal
Maron, Martin S.
Nezafat, Reza
Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy
title Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy
title_full Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy
title_fullStr Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy
title_full_unstemmed Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy
title_short Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy
title_sort radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235098/
https://www.ncbi.nlm.nih.gov/pubmed/35761339
http://dx.doi.org/10.1186/s12968-022-00869-x
work_keys_str_mv AT fahmyahmeds radiomicsanddeeplearningformyocardialscarscreeninginhypertrophiccardiomyopathy
AT rowinethanj radiomicsanddeeplearningformyocardialscarscreeninginhypertrophiccardiomyopathy
AT arafatiarghavan radiomicsanddeeplearningformyocardialscarscreeninginhypertrophiccardiomyopathy
AT alotaibitalal radiomicsanddeeplearningformyocardialscarscreeninginhypertrophiccardiomyopathy
AT maronmartins radiomicsanddeeplearningformyocardialscarscreeninginhypertrophiccardiomyopathy
AT nezafatreza radiomicsanddeeplearningformyocardialscarscreeninginhypertrophiccardiomyopathy